Zicam and Orajel
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
In December 2015, a class-action lawsuit was filed against Zicam for allegedly deceptively marketing Zicam Pre-Cold Medicine products – including RapidMelts, Oral Mist, Ultra Crystals, Lozenges, and Chewables – as having the ability to treat cold symptoms without adequate evidence to support such claims and when scientific evidence shows that the products are “nothing more than a placebo.” (Gulkis et al v. Zicam LLC and Matrixx Initiatives, Inc., Case No. 15-cv-9843, S. D. NY.)
For more information about other class-action lawsuits regarding products claiming to treat cold symptoms and TINA.org’s coverage of them, click here.
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
TINA.org digs into company’s subscription terms.
TINA.org urges the FTC to adopt a fee disclosure rule for the online food delivery market.
Comment pushes for strong oversight of supplement companies targeting kids.
TINA.org complaint with FTC and DOJ urges renewed action to stop serial offender.
MADISON, CONN. May 12, 2026 – Legacy Cremation Services continues to prey on grieving families nationwide despite a federal court order intended to stop its deceptive practices, according to a…